论文部分内容阅读
缺血再灌注损伤(ischemia reperfusion injury,IRI)是临床上常见的病理生理现象,其发生机制尚未完全清楚。如何降低由IRI所引起的组织器官损害,促进其恢复是临床医学的研究重点。本文就抗坏血酸在IRI中的保护机制进行综述。
Ischemic reperfusion injury (IRI) is a common clinical pathophysiological phenomenon, the mechanism of which is not yet fully understood. How to reduce the tissue damage caused by IRI and promote their recovery is the focus of clinical research. This article reviews the mechanism of protection of ascorbic acid in IRI.